Cardlytics, INC Form 4 insider transactions

Amit Gupta, Chief Executive Officer and a Director of Cardlytics, Inc., sold 17,733 shares of common stock on October 1, 2026.

Liane Hornsey, a Director of Cardlytics, Inc., received 2,200 shares of common stock on May 20, 2026.

Srishti A. Gupta, a Director of Cardlytics, Inc., received 2,200 shares of common stock on May 20, 2026.

Jonathan Edward Francis, a Director of Cardlytics, Inc., received 2,200 shares of common stock on May 20, 2026.

Andre J Fernandez, a Director of Cardlytics, Inc., received 2,200 shares of common stock on May 20, 2026.

John L. Klinck Jr., a Director of Cardlytics, Inc., received 2,200 shares of common stock on May 20, 2026.

Scott A Hill, a Director of Cardlytics, Inc., received 2,200 shares of common stock on May 20, 2026.

Amit Gupta, Chief Executive Officer and a Director of Cardlytics, Inc., sold 13,461 shares of common stock on August 16, 2026.

Christopher Chi-Kit Cheng, Chief Legal & Privacy Officer of Cardlytics, Inc., received 50,000 shares of common stock on August 3, 2026.

Cardlytics CEO Amit Gupta reported transactions involving the sale of company stock following a 1-for-10 reverse stock split.

Nicholas Hollmeyer, Chief Legal & Privacy Officer at Cardlytics, Inc., reported transactions involving the acquisition and disposition of common stock and restricted stock units.

Cardlytics, Inc. director Srishti A. Gupta acquired 11,000 shares of common stock through the vesting of restricted stock units.

Cardlytics, Inc. Director Scott A. Hill reported the acquisition of 11,000 shares of common stock through the vesting of restricted stock units.

Director Andre Fernandez reported the acquisition of 11,000 restricted stock units of Cardlytics, Inc. (CDLX) on May 20, 2026.

Director Liane Hornsey reported the acquisition of 11,000 restricted stock units of Cardlytics, Inc. on May 20, 2026.

John L. Klinck Jr., a Director at Cardlytics, Inc., acquired 11,000 shares of common stock through the vesting of restricted stock units.

Cardlytics, Inc. Chief Financial Officer David Thomas Evans acquired a significant number of company shares through multiple transactions in mid-May 2026.

Cardlytics, Inc. CEO Amit Gupta sold 69,833 shares of common stock to cover tax obligations from vested RSUs.

Cardlytics CEO Amit Gupta reported transactions involving the sale of company stock to cover tax obligations from vested Restricted Stock Units (RSUs).

Cardlytics Chief Legal Officer Nicholas Hollmeyer sold shares to cover tax obligations upon RSU vesting.

Cardlytics, Inc. Chief Financial Officer David Thomas Evans was granted 1,000,000 Restricted Stock Units under a Rule 10b5-1(c) plan.

Cardlytics' Chief Legal & Privacy Officer, Nicholas Lynton, sold 6,253 shares of common stock to cover tax withholdings from vested restricted stock units.

Cardlytics CEO Amit Gupta sold 5,807 shares of common stock at a weighted average price of $1.17 to cover tax withholding obligations from RSU vesting.

Cardlytics' Chief Financial Officer, Alexis DeSieno, sold shares to cover tax obligations following the vesting of restricted stock units.

Cardlytics Director Srishti A. Gupta acquired 6,148 shares of common stock through the vesting and conversion of restricted stock units on October 30, 2025.

Cardlytics Chief Legal & Privacy Officer, Nicholas Lynton, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax withholding obligations.

Cardlytics CEO Amit Gupta exercised restricted stock units and subsequently sold a portion of the common stock to satisfy tax withholding obligations.

Cardlytics CFO Alexis DeSieno sold 8,493 shares of common stock to cover tax withholdings following the vesting of 14,350 restricted stock units.

Cardlytics Director and 10% owner Clifford Sosin sold 400,000 shares of common stock over two days in August 2025.

Cardlytics CEO Amit Gupta sold 136,945 shares of common stock to cover tax withholding obligations following the vesting of 250,000 restricted stock units.